510(k) Report

510(k) · Cleared

Cleared

Nexodyn AOS Wound Care Solution

K151168510(k) TraditionalCleared Dec 22, 2015235-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Apr Applied Pharma Research SA · FRO Dressing, Wound, Drug

Cleared on Dec 22, 2015 as substantially equivalent to K113820 (Novabay Pharmaceuticals, 2012) and 1 other predicate after a 235-day review. Its family tree reaches back 9 generations to 1992.

Decided
Dec 22, 2015
Review
235 days
Class
Class U
Product code
FRO
Recalls
None
Predicates
2

Its longest line of descent runs back 9 generations to K914579 (1992). 40 ancestors in all, the oldest K830708 (1983). No later device cites it as a predicate yet.

  1. Root · 9 generations backK914579 Silver Foam Wound DressingVitaphore Corp. · 1992
  2. 5 generations between
  3. 3 generations backK090206 Oculus Puracyn Antimicrobial Skin and Wound CleanserOculus Innovative Sciences, Inc. · 2009 · Recalled
  4. 2 generations backK100918 Vashe Wound Therapy System Model: 9000-0014Puricore, Inc. · 2010
  5. 1 generation backK113820 Neutrophase Antimicrobial Wound CleanserNovabay Pharmaceuticals · 2012
  6. This deviceK151168 Nexodyn AOS Wound Care SolutionApr Applied Pharma Research SA · 2015
Show all 9 generations
  1. Root · 9 generations backK914579 Silver Foam Wound DressingVitaphore Corp. · 1992
  2. 8 generations backK955453 Acticoat Silver Coated DressingWestaim Technologies, Inc. · 1996
  3. 7 generations backK981299 Silverlon Contact Wound DressingArgentum International, LLC · 1998
  4. 6 generations backK023612 Silverlon Contact Wound DressingArgentum International, LLC · 2003
  5. 5 generations backK063069 Silvaklenz Skin and Wound Clenser SolutionMedical Molecular Therapuetics, LLC · 2007
  6. 4 generations backK073547 Anasept Antimicrobial Skin and Wound Cleansers; Anasept…Anacapa Technologies, Inc. · 2008
  7. 3 generations backK090206 Oculus Puracyn Antimicrobial Skin and Wound CleanserOculus Innovative Sciences, Inc. · 2009 · Recalled
  8. 2 generations backK100918 Vashe Wound Therapy System Model: 9000-0014Puricore, Inc. · 2010
  9. 1 generation backK113820 Neutrophase Antimicrobial Wound CleanserNovabay Pharmaceuticals · 2012
  10. This deviceK151168 Nexodyn AOS Wound Care SolutionApr Applied Pharma Research SA · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K914579Silver Foam Wound DressingVitaphore Corp.1992—
−8K955453Acticoat Silver Coated DressingWestaim Technologies, Inc.1996—
−7K981299Silverlon Contact Wound DressingArgentum International, LLC1998—
−6K023612Silverlon Contact Wound DressingArgentum International, LLC2003—
−5K063069Silvaklenz Skin and Wound Clenser SolutionMedical Molecular Therapuetics, LLC2007—
−4K073547Anasept Antimicrobial Skin and Wound Cleansers; Anasept Antimicrobial Skin and…Anacapa Technologies, Inc.2008—
−3K090206Oculus Puracyn Antimicrobial Skin and Wound CleanserOculus Innovative Sciences, Inc.20093
−2K100918Vashe Wound Therapy System Model: 9000-0014Puricore, Inc.2010—
−1K113820Neutrophase Antimicrobial Wound CleanserNovabay Pharmaceuticals2012—
0 (this device)K151168Nexodyn AOS Wound Care SolutionApr Applied Pharma Research SA2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198310
198920
199010
199310
199530
199730
199820
199940
200130
200230
200410
200510
200620
200710
200810
200910
201310
FIG. 1 — Lineage of K151168, 1992–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FRO device

  1. #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113820Neutrophase Antimicrobial Wound Cleanser
Summary page 6
…oPhase Skin and Wound Cleanser Sponsor: .............................................. NovaBay Pharmaceuticals, Inc 510(k) Number: .................................... K113820 Clearance Date: ................................... 8 August 2012 FDA Product Code: ............................. FRO Classifi…
Novabay Pharmaceuticals2012—
*K123072Vashe Wound Therapy Solution
Summary page 6
…............... Vashe Wound Therapy Solution Sponsor: .............................................. PuriCore, Inc. 510(k) Number: .................................... K123072 Clearance Date: ................................... 14 February 2013 FDA Product Code: ............................. FRO Class…
Puricore, Inc.2013—

Also cleared against K113820: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 9 companies; a new generation was cleared every 2.3 years on median.
  • 1 of the 40 ancestors has a recall of any class.
  • 4 other devices also cite its predicate K113820.

How does its category compare?

All FRO devices

FRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · FRO

11in 2025

2007: 292008: 262009: 312010: 312011: 272012: 242013: 192014: 222015: 282016: 282017: 232018: 202019: 162020: 122021: 82022: 92023: 182024: 242025: 112026 (partial year): 17
2007high 31 (2009) · low 8 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FRO

176in 2025

2007: 187 days median2008: 130 days median2009: 136 days median2010: 146 days median2011: 177 days median2012: 96 days median2013: 194 days median2014: 214 days median2015: 249 days median2016: 222 days median2017: 147 days median2018: 206 days median2019: 270 days median2020: 226 days median2021: 275 days median2022: 332 days median2023: 283 days median2024: 263 days median2025: 176 days median2026 (partial year): 254 days median
2007high 332 (2022) · low 96 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FRO

2in 2024

2007: 42008: 12009: 12011: 42013: 12014: 12015: 22016: 32017: 12019: 12021: 62022: 22023: 2, 2 Class I2024: 22026 (partial year): 2
2007high 6 (2021) · low 0 (2010)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · FRO

192in 2025

2007: 552008: 302009: 452010: 1222011: 422012: 652013: 1392014: 2692015: 2972016: 1472017: 1492018: 1282019: 1362020: 1392021: 1832022: 1762023: 1982024: 2322025: 192
2007high 297 (2015) · low 30 (2008)2025

MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200729187455
200826130130
200931136145
2010311460122
201127177442
20122496065
2013191941139
2014222141269
2015282492297
2016282223147
2017231471149
2018202060128
2019162701136
2020122260139
202182756183
202293322176
2023182832 (2)198
2024242632232
2025111760192
2026172542—

What is it indicated for?

Nexodyn AOS Wound Care Solution is intended for use under the supervision of healthcare professionals for cleansing, irrigating, moistening and debriding, to remove organic and inorganic debris from partial or full thickness acute and chronic dermal lesions, such as leg ulcers, stasis ulcers, diabetic ulcers, stage I-IV pressure ulcers, post-surgical wounds, grafted and donor sites and 1st and 2nd degree burns, together with cleansing and moistening minor cuts, minor burns, superficial abrasions and minor skin irritations.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K151168: Nexodyn AOS Wound Care Solution.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K151168

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026